| pubmed-article:11310281 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11310281 | lifeskim:mentions | umls-concept:C0042789 | lld:lifeskim |
| pubmed-article:11310281 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
| pubmed-article:11310281 | lifeskim:mentions | umls-concept:C0015214 | lld:lifeskim |
| pubmed-article:11310281 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:11310281 | lifeskim:mentions | umls-concept:C0282541 | lld:lifeskim |
| pubmed-article:11310281 | lifeskim:mentions | umls-concept:C0016884 | lld:lifeskim |
| pubmed-article:11310281 | lifeskim:mentions | umls-concept:C0332120 | lld:lifeskim |
| pubmed-article:11310281 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11310281 | pubmed:dateCreated | 2001-4-19 | lld:pubmed |
| pubmed-article:11310281 | pubmed:abstractText | To analyze the character as pathophysiological marker of the P300 component in the evaluation of schizophrenic illness. We therefore review clinical and neuropsychological evidence of studies in which this was used as a tool for evaluation to reach a diagnosis. | lld:pubmed |
| pubmed-article:11310281 | pubmed:language | spa | lld:pubmed |
| pubmed-article:11310281 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11310281 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11310281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11310281 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11310281 | pubmed:issn | 0210-0010 | lld:pubmed |
| pubmed-article:11310281 | pubmed:author | pubmed-author:MolinaVV | lld:pubmed |
| pubmed-article:11310281 | pubmed:author | pubmed-author:MuñozFF | lld:pubmed |
| pubmed-article:11310281 | pubmed:author | pubmed-author:PozoM AMA | lld:pubmed |
| pubmed-article:11310281 | pubmed:author | pubmed-author:Martín-Loeche... | lld:pubmed |
| pubmed-article:11310281 | pubmed:author | pubmed-author:HinojosaJ AJA | lld:pubmed |
| pubmed-article:11310281 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11310281 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:11310281 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11310281 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11310281 | pubmed:pagination | 250-8 | lld:pubmed |
| pubmed-article:11310281 | pubmed:dateRevised | 2009-5-28 | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:meshHeading | pubmed-meshheading:11310281... | lld:pubmed |
| pubmed-article:11310281 | pubmed:articleTitle | [The P300 component of evoked potentials in the evaluation of schizophrenia: new evidence and future visions]. | lld:pubmed |
| pubmed-article:11310281 | pubmed:affiliation | Unidad de Cartografía Cerebral, Instituto Pluridisciplinar, Universidad Complutense, España. mmartin@eucmax.sim.ucm.es | lld:pubmed |
| pubmed-article:11310281 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11310281 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:11310281 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:11310281 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
